Related Experiment Video
Updated: Jul 10, 2025

Software-Assisted Quantitative Measurement of Osteoarthritic Subchondral Bone Thickness
Published on: March 18, 2022
TMT quantitative proteomics reveals key proteins relevant to microRNA-1-mediated regulation in osteoarthritis
Pinpin Jiang1,2, Dan Liang2,3, Hang Wang4
1Department of Orthopaedic Surgery, the Second Hospital of Shanxi Medical University, Taiyuan, 030001, Shanxi, China.
Abstract:
Osteoarthritis (OA) is the second-commonest arthritis, but pathogenic and regulatory mechanisms underlying OA remain incompletely understood. Here, we aimed to identify the mechanisms associated with microRNA-1 (miR-1) treatment of OA in rodent OA models using a proteomic approach. First, N = 18 Sprague Dawley (SD) rats underwent sham surgery (n = 6) or ACL transection (n = 12), followed at an interval of one week by randomization of the ACL transection group to intra-articular administration of either 50 µL placebo (control group) or miR-1 agomir, a mimic of endogenous miR-1 (experimental group). After allowing for eight weeks of remodeling, articular cartilage tissue was harvested and immunohistochemically stained for the presence of MMP-13. Second, N = 30 Col2a1-cre-ERT2 /GFPf1/fl -RFP-miR-1 transgenic mice were randomized to intra-articular administration of either placebo (control group, N = 15) or tamoxifen, an inducer of miR-1 expression (experimental group, N = 15), before undergoing surgical disruption of the medial meniscus (DMM) after an interval of five days. After allowing for eight weeks of remodeling, articular cartilage tissue was harvested and underwent differential proteomic analysis. Specifically, tandem mass tagging (TMT) quantitative proteomic analysis was employed to identify inter-group differentially-expressed proteins (DEP), and selected DEPs were validated using real-time quantitative polymerase chain reaction (RT-qPCR) technology. Immunohistochemically-detected MMP-13 expression was significantly lower in the experimental rat group, and proteomic analyses of mouse tissue homogenate demonstrated that of 3526 identified proteins, 345 were differentially expressed (relative up- and down-regulation) in the experimental group. Proteins Fn1, P4ha1, P4ha2, Acan, F2, Col3a1, Fga, Rps29, Rpl34, and Fgg were the *top ten most-connected proteins, implying that miR-1 may regulate an expression network involving these proteins. Of these ten proteins, three were selected for further validation by RT-qPCR: the transcript of Fn1, known to be associated with OA, exhibited relative upregulation in the experimental group, whereas the transcripts of P4ha1 and Acan exhibited relative downregulation. These proteins may thus represent key miR-1 targets during OA-regulatory mechanisms, and may provide additional insights regarding therapeutic mechanisms of miR-1 in context of OA.
Insights
MicroRNA-1 (miR-1) treatment reduced MMP-13 expression in rodent osteoarthritis models. Proteomic analysis identified key proteins regulated by miR-1, offering insights into osteoarthritis therapeutic mechanisms.
Area of Science:
- Molecular Biology
- Proteomics
- Osteoarthritis Research
Background:
- Osteoarthritis (OA) is a prevalent degenerative joint disease with incompletely understood pathogenic mechanisms.
- MicroRNAs, such as microRNA-1 (miR-1), are implicated in regulating gene expression and cellular processes relevant to OA.
- Identifying the molecular targets and regulatory networks of miR-1 is crucial for understanding its therapeutic potential in OA.
Purpose of the Study:
- To investigate the mechanisms of microRNA-1 (miR-1) treatment in rodent models of osteoarthritis (OA).
- To identify differentially expressed proteins (DEPs) regulated by miR-1 in OA cartilage using a proteomic approach.
- To elucidate the potential therapeutic mechanisms of miR-1 in OA pathogenesis.
Main Methods:
- Rodent models of osteoarthritis were established using anterior cruciate ligament transection in rats and destabilization of the medial meniscus (DMM) in mice.
- Intra-articular administration of miR-1 agomir (rats) or tamoxifen to induce miR-1 expression (mice) was performed.
- Tandem mass tagging (TMT) quantitative proteomic analysis was used to identify DEPs, followed by RT-qPCR validation of selected targets.
Main Results:
- Immunohistochemical analysis showed significantly lower MMP-13 expression in miR-1 treated rats.
- Proteomic analysis in mice identified 345 differentially expressed proteins out of 3526 identified proteins.
- Key proteins including Fn1, P4ha1, and Acan were identified as potential miR-1 targets, with validated differential expression of their transcripts.
Conclusions:
- MicroRNA-1 (miR-1) demonstrates therapeutic potential in osteoarthritis by modulating key protein expression networks.
- Proteomic analysis successfully identified novel miR-1 targets, such as Fn1, P4ha1, and Acan, involved in OA regulation.
- These findings provide valuable insights into the molecular mechanisms underlying miR-1's therapeutic effects in osteoarthritis.
More Related Videos
12:23Flow Cytometry Analysis of Immune Cell Subsets within the Murine Spleen, Bone Marrow, Lymph Nodes and Synovial Tissue in an Osteoarthritis Model
Published on: April 24, 2020
12:44Creation of a Knee Joint-on-a-Chip for Modeling Joint Diseases and Testing Drugs
Published on: January 27, 2023